Oxytocin Revisited: Its Role in Cardiovascular Regulation

Journal of Neuroendocrinology

Volumn 24, Issue 4, 2012, Pages 599-608

  Gutkowska, J ^a   Jankowski, M ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Cardiomyogenesis; Heart; Natriuretic peptides; Oxytocin

Indexed keywords

ARGININE; ATRIAL NATRIURETIC FACTOR; CELL MARKER; GLYCINE; LYSINE; NITRIC OXIDE; OXYTOCIN; OXYTOCIN GLYCYLLYSYLARGININE; OXYTOCIN RECEPTOR; TRIPEPTIDE; UNCLASSIFIED DRUG; VASOPRESSIN;

ANGIOGENESIS; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; CELL CULTURE; CHRONOTROPISM; ENDOTHELIUM CELL; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; HEART INFARCTION; HEART MUSCLE CELL; HEART PROTECTION; HEART WORK; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; HYPOXIA; INOTROPISM; INSULIN RESISTANCE; MESENCHYME CELL; METABOLISM; MUSCLE DEVELOPMENT; NEUROMODULATION; NONHUMAN; OSMORECEPTOR; PARASYMPATHETIC NERVE CELL; PRESSORECEPTOR; PRIORITY JOURNAL; REVIEW; STEM CELL; VASODILATATION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CARDIOVASCULAR SYSTEM; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; HUMANS; MODELS, BIOLOGICAL; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; OXYTOCIN; RECEPTORS, OXYTOCIN;

EID: 84858802137     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2011.02235.x     Document Type: Review

References (101)

1. Oliver G, Schafer EA. On the physiological action of extracts of pituitary body and certain other glandular organs: preliminary communication. J Physiol 1895; 18: 277-279.
2. Howell WH. A contribution to the physiology of sleep, based upon plethysmographic experiments. J Exp Med 1897; 2: 313-345.
3. Dale HH. On some physiological actions of ergot. J Physiol 1906; 34: 163-206.
4. Dale HH. The actions of extracts of pituitary body. Biochem J 1910; 4: 427-447.
5. Kamm O, Aldrich TB, Grote IW, Rowe LW, Bugbee EP. Active principles of the posterior lobe of the pituitary gland. J Am Chem Soc 1928; 50: 573-601.
6. Gaddum JH. Some properties of the separated active principles of the pituitary (posterior lobe). J Physiol 1928; 65: 434-440.
7. Fraser AM. The action of the oxytocin hormone of the pituitary gland on urine secretion. J Physiol 1942; 101: 236-251.
8. Ott I, Scott JC. The action of infundibulin upon the mammary secretion. Proc Soc Exp Biol Med 1910; 8: 48-49.
9. Du Vigneaud V, Ressler C, Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J Biol Chem 1953; 205: 949-957.
10. Woodbury RA, Abreu BE. Influence of oxytocin (pitocin) upon the heart and blood pressure of the chicken, rabbit, cat, dog and turtle. Am J Physiol 1944; 142: 114-120.
11. Kitchin AH, Lloyd SM, Pickford M. Some actions of oxytocin on the cardiovascular system in man. Clin Sci 1959; 18: 399-406.
12. Nakano J, Fisher RD. Studies on the cardiovascular effects of synthetic oxytocin. J Pharmacol Exp Ther 1963; 142: 206-214.
13. Cross RB, Dicker SE, Kitchin AH, Lloyd S, Pickford M. The effect of oxytocin on the urinary excretion of water and electrolytes in man. J Physiol 1960; 153: 553-561.
14. Sedlakova E, Lichardus B, Cort JH. Plasma saluretic activity: its nature and relation to oxytocin analogs. Science 1969; 164: 580-582.
15. Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci USA 1996; 93: 11699-11704.
16. Petersson M. Cardiovascular effects of oxytocin. Prog Brain Res 2002; 139: 281-288.
17. Gutkowska J, Jankowski M, Mukaddam-Daher S, McCann SM. Oxytocin is a cardiovascular hormone. Braz J Med Biol Res 2000; 33: 625-633.
18. Andersson B, McCann SM. The effect of hypothalamic lesions on the water intake of the dog. Acta Physiol Scand 1956; 35: 313-320.
19. Andersson B, Jobin M, Olsson K. Stimulation of urinary salt excretion following injections of hypertonic NaCl-solution into the 3rd brain ventricle. Acta Physiol Scand 1966; 67: 127-128.
20. De Bold AJ, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94.
21. DeWardener HE, Clarkson EL. Natriuretic Hormone. New York, NY: Raven Press, 1985: 1013-1031.
22. Davis JO, Freeman RH. Mechanisms regulating renin release. Physiol Rev 1976; 56: 1-56.
23. Cort JH, Lichardus B, Pliska V, Barth T, Uhrin V, Rudinger J. In:Margoulies J, eds. Protein and polypeptide hormones. Amsterdam: Excerpta Medica, 1969; 939.
24. Morris M, McCann SM, Orias R. Evidence for hormonal participation in the natriuretic and kaliuretic responses to intraventricular hypertonic saline and norepinephrine. Proc Soc Exp Biol Med 1976; 152: 95-98.
25. Gauer OH, Henry JP. Circulatory basis of fluid volume control. Physiol Rev 1963; 43: 423-481.
26. Sudoh T, Minamino N, Kangawa K, Matsuo H. Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem Biophys Res Commun 1988; 155: 726-732.
27. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor b. Possible existence of vascular natriuretic peptide system. J Clin Invest 1992; 90: 1145-1149.
28. Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992; 44: 479-602.
29. Horio T, Nishikimi T, Yoshihara F, Matsuo H, Takishita S, Kangawa K. Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 2000; 35: 19-24.
30. Cao L, Gardner DG. Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 1995; 25: 227-234.
31. Palkovits M, Eskay RL, Antoni FA. Atrial natriuretic peptide in the median eminence is of paraventricular nucleus origin. Neuroendocrinology 1987; 46: 542-544.
32. Baldissera S, Menani JW, Sotero dos Santos LF, Favaretto AL, Gutkowska J, Turrin MQ, McCann SM, Antunes-Rodrigues J. Role of the hypothalamus in the control of atrial natriuretic peptide release. Proc Natl Acad Sci USA 1989; 86: 9621-9625.
33. Antunes-Rodrigues J, Ramalho MJ, Reis LC, Menani JV, Turrin MQ, Gutkowska J, McCann SM. Lesions of the hypothalamus and pituitary inhibit volume-expansion-induced release of atrial natriuretic peptide. Proc Natl Acad Sci USA 1991; 88: 2956-2960.
34. Antunes-Rodrigues J, Machado BH, Andrade HA, Mauad H, Ramalho MJ, Reis LC, Silva-Netto CR, Favaretto AL, Gutkowska J, McCann SM. Carotid-aortic and renal baroreceptors mediate the atrial natriuretic peptide release induced by blood volume expansion. Proc Natl Acad Sci USA 1992; 89: 6828-6831.
35. Antunes-Rodrigues J, Marubayashi U, Favaretto AL, Gutkowska J, McCann SM. Essential role of hypothalamic muscarinic and a-adrenergic receptors in atrial natriuretic peptide release induced by blood volume expansion. Proc Natl Acad Sci USA 1993; 90: 10240-10244.
36. Reis LC, Ramalho MJ, Favaretto AL, Gutkowska J, McCann SM, Antunes-Rodrigues J. Participation of the ascending serotonergic system in the stimulation of atrial natriuretic peptide release. Proc Natl Acad Sci USA 1994; 91: 12022-12026.
37. Haanwinckel MA, Elias LK, Favaretto AL, Gutkowska J, McCann SM, Antunes-Rodrigues J. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA 1995; 92: 7902-7906.
38. Soares TJ, Coimbra TM, Martins AR, Pereira AG, Carnio EC, Branco LG, Albuquerque-Araujo WI, De Nucci G, Favaretto AL, Gutkowska J, McCann SM, Antunes-Rodrigues J. Atrial natriuretic peptide and oxytocin induce natriuresis by release of cGMP. Proc Natl Acad Sci USA 1999; 96: 278-283.
39. Gutkowska J, Jankowski M, Lambert C, Mukaddam-Daher S, Zingg HH, McCann SM. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 1997; 94: 11704-11709.
40. Jankowski M, Hajjar F, Al Kawas S, Mukaddam-Daher S, Hoffman G, McCann SM, Gutkowska J. Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci USA 1998; 95: 14558-14563.
41. Jankowski M, Wang D, Hajjar F, Mukaddam-Daher S, McCann SM, Gutkowska J. Oxytocin and its receptors are synthesized in the rat vasculature. Proc Natl Acad Sci USA 2000; 97: 6207-6211.
42. Adan RA, Van Leeuwen FW, Sonnemans MA, Brouns M, Hoffman G, Verbalis JG, Burbach JP. Rat oxytocin receptor in brain, pituitary, mammary gland, and uterus: partial sequence and immunocytochemical localization. Endocrinology 1995; 136: 4022-4028.
43. Adan RA, Van Leeuwen FW, Sonnemans MA, Hoffman G, Verbalis JG, Burbach JP. The rat oxytocin receptor. cDNA cloning and immunocytochemical localization in brain, pituitary, mammary gland and uterus. Adv Exp Med Biol 1995; 395: 345-346.
44. Cicutti NJ, Smyth CE, Rosaeg OP, Wilkinson M. Oxytocin receptor binding in rat and human heart. Can J Cardiol 1999; 15: 1267-1273.
45. Favaretto AL, Ballejo GO, Albuquerque-Araujo WI, Gutkowska J, Antunes-Rodrigues J, McCann SM. Oxytocin releases atrial natriuretic peptide from rat atria in vitro that exerts negative inotropic and chronotropic action. Peptides 1997; 18: 1377-1381.
46. Nishimori K, Takayanagi Y, Yoshida M, Kasahara Y, Young LJ, Kawamata M. New aspects of oxytocin receptor function revealed by knockout mice: sociosexual behaviour and control of energy balance. Prog Brain Res 2008; 170: 79-90.
47. Bernatova I, Rigatto KV, Key MP, Morris M. Stress-induced pressor and corticosterone responses in oxytocin-deficient mice. Exp Physiol 2004; 89: 549-557.
48. Ondrejcakova M, Ravingerova T, Bakos J, Pancza D, Jezova D. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion. Can J Physiol Pharmacol 2009; 87: 137-142.
49. Mukaddam-Daher S, Lin YL, Roy J, Gutkowska J, Cardinal R. Negative inotropic and chronotropic effects of oxytocin. Hypertension 2001; 38: 292-296.
50. Cattaneo MG, Lucci G, Vicentini LM. Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism. Exp Cell Res 2009; 315: 3210-3219.
51. Thibonnier M, Conarty DM, Preston JA, Plesnicher CL, Dweik RA, Erzurum SC. Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999; 140: 1301-1309.
52. Sirotkin AV, Florkovicova I, Makarevich AV, Schaeffer HJ, Kotwica J, Marnet PG, Sanislo P. Oxytocin mediates some effects of insulin-like growth factor-I on porcine ovarian follicles. J Reprod Dev 2003; 49: 141-149.
53. Gutkowska J, Broderick TL, Bogdan D, Wang D, Lavoie JM, Jankowski M. Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy. J Physiol 2009; 587: 4725-4736.
54. Florian M, Jankowski M, Gutkowska J. Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology 2010; 151: 482-491.
55. Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin ameliorates oxidative colonic inflammation by a neutrophil-dependent mechanism. Peptides 2005; 26: 483-491.
56. Iseri SO, Sener G, Saglam B, Gedik N, Ercan F, Yegen BC. Oxytocin protects against sepsis-induced multiple organ damage: role of neutrophils. J Surg Res 2005; 126: 73-81.
57. Pfister O, Mouquet F, Jain M, Summer R, Helmes M, Fine A, Colucci WS, Liao R. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res 2005; 97: 52-61.
58. Szeto A, Nation DA, Mendez AJ, Dominguez-Bendala J, Brooks LG, Schneiderman N, McCabe PM. Oxytocin attenuates NADPH-dependent superoxide activity and IL-6 secretion in macrophages and vascular cells. Am J Physiol Endocrinol Metab 2008; 295: E1495-E1501.
59. Kim YS, Kwon JS, Hong MH, Kim J, Song CH, Jeong MH, Cho JG, Park JC, Kang JC, Ahn Y. Promigratory activity of oxytocin on umbilical cord blood-derived mesenchymal stem cells. Artif Organs 2010; 34: 453-461.
60. Oyama T, Nagai T, Wada H, Naito AT, Matsuura K, Iwanaga K, Takahashi T, Goto M, Mikami Y, Yasuda N, Akazawa H, Uezumi A, Takeda S, Komuro I. Cardiac side population cells have a potential to migrate and differentiate into cardiomyocytes in vitro and in vivo. J Cell Biol 2007; 176: 329-341.
61. McCann SM, Antunes-Rodrigues J, Jankowski M, Gutkowska J. Oxytocin, vasopressin and atrial natriuretic peptide control body fluid homeostasis by action on their receptors in brain, cardiovascular system and kidney. Prog Brain Res 2002; 139: 309-328.
62. Jankowski M, Bissonauth V, Gao L, Gangal M, Wang D, Danalache B, Wang Y, Stoyanova E, Clouthier G, Blaise G, Gutkowska J. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol 2010; 105: 205-218.
63. Alizadeh AM, Faghihi M, Sadeghipour HR, Mohammadghasemi F, Imani A, Houshmand F, Khori V. Oxytocin protects rat heart against ischemia-reperfusion injury via pathway involving mitochondrial ATP-dependent potassium channel. Peptides 2010; 31: 1341-1345.
64. Houshmand F, Faghihi M, Zahediasl S. Biphasic protective effect of oxytocin on cardiac ischemia/reperfusion injury in anaesthetized rats. Peptides 2009; 30: 2301-2308.
65. Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S. Post-infarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis. J Cardiovasc Pharmacol 2009; 54: 510-519.
66. Cantley LC. The phosphoinositide 3-kinase pathway. Science 2002; 296: 1655-1657.
67. Fujio Y, Nguyen T, Wencker D, Kitsis RN, Walsh K. Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation 2000; 101: 660-667.
68. Miike T, Kunishiro K, Kanda M, Azukizawa S, Kurahashi K, Shirahase H. Impairment of endothelium-dependent ACh-induced relaxation in aorta of diabetic db/db mice - possible dysfunction of receptor and/or receptor-G protein coupling. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 401-410.
69. Lee ES, Uhm KO, Lee YM, Kwon J, Park SH, Soo KH. Oxytocin stimulates glucose uptake in skeletal muscle cells through the calcium-CaMKK-AMPK pathway. Regul Pept 2008; 151: 71-74.
70. Russell RR III, Li J, Coven DL, Pypaert M, Zechner C, Palmeri M, Giordano FJ, Mu J, Birnbaum MJ, Young LH. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J Clin Invest 2004; 114: 495-503.
71. Devost D, Wrzal P, Zingg HH. Oxytocin receptor signalling. Prog Brain Res 2008; 170: 167-176.
72. Gimpl G, Fahrenholz F. The oxytocin receptor system: structure, function, and regulation. Physiol Rev 2001; 81: 629-683.
73. Nation DA, Szeto A, Mendez AJ, Brooks LG, Zaias J, Herderick EE, Gonzales J, Noller CM, Schneiderman N, McCabe PM. Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE-/- mice. Psychosom Med 2010; 72: 376-382.
74. Cassoni P, Marrocco T, Bussolati B, Allia E, Munaron L, Sapino A, Bussolati G. Oxytocin induces proliferation and migration in immortalized human dermal microvascular endothelial cells and human breast tumor-derived endothelial cells. Mol Cancer Res 2006; 4: 351-359.
75. Cattaneo MG, Chini B, Vicentini LM. Oxytocin stimulates migration and invasion in human endothelial cells. Br J Pharmacol 2008; 153: 728-736.
76. Jankowski M, Wang D, Danalache B, Gangal M, Gutkowska J. Cardiac oxytocin receptor blockade stimulates adverse cardiac remodeling in ovariectomized spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2010; 299: H265-H274.
77. Jankowski M, Danalache B, Wang D, Bhat P, Hajjar F, Marcinkiewicz M, Paquin J, McCann SM, Gutkowska J. Oxytocin in cardiac ontogeny. Proc Natl Acad Sci USA 2004; 101: 13074-13079.
78. Paquin J, Danalache BA, Jankowski M, McCann SM, Gutkowska J. Oxytocin induces differentiation of P19 embryonic stem cells to cardiomyocytes. Proc Natl Acad Sci USA 2002; 99: 9550-9555.
79. van der Heyden MA, Defize LH. Twenty-one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation. Cardiovasc Res 2003; 58: 292-302.
80. McBurney MW. P19 embryonal carcinoma cells. Int J Dev Biol 1993; 37: 135-140.
81. Danalache BA, Paquin J, Donghao W, Grygorczyk R, Moore JC, Mummery CL, Gutkowska J, Jankowski M. Nitric oxide signaling in oxytocin-mediated cardiomyogenesis. Stem Cells 2007; 25: 679-688.
82. Gassanov N, Devost D, Danalache B, Noiseux N, Jankowski M, Zingg HH, Gutkowska J. Functional activity of the carboxyl-terminally extended oxytocin precursor peptide during cardiac differentiation of embryonic stem cells. Stem Cells 2008; 26: 45-54.
83. Gassanov N, Er F, Zagidullin N, Jankowski M, Gutkowska J, Hoppe UC. Retinoid acid-induced effects on atrial and pacemaker cell differentiation and expression of cardiac ion channels. Differentiation 2008; 76: 971-980.
84. Gassanov N, Jankowski M, Danalache B, Wang D, Grygorczyk R, Hoppe UC, Gutkowska J. Arginine vasopressin-mediated cardiac differentiation: insights into the role of its receptors and nitric oxide signaling. J Biol Chem 2007; 282: 11255-11265.
85. Matsuura K, Nagai T, Nishigaki N, Oyama T, Nishi J, Wada H, Sano M, Toko H, Akazawa H, Sato T, Nakaya H, Kasanuki H, Komuro I. Adult cardiac Sca-1-positive cells differentiate into beating cardiomyocytes. J Biol Chem 2004; 279: 11384-11391.
86. Mouquet F, Pfister O, Jain M, Oikonomopoulos A, Ngoy S, Summer R, Fine A, Liao R. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res 2005; 97: 1090-1092.
87. Gutkowska J, Miszkurka M, Danalache B, Gassanov N, Wang D, Jankowski M. Functional arginine-vasopressin system in early heart maturation. Am J Physiol Heart Circ Physiol 2007; 293: H2262-H2270.
88. Bisping E, Ikeda S, Kong SW, Tarnavski O, Bodyak N, McMullen JR, Rajagopal S, Son JK, Ma Q, Springer Z, Kang PM, Izumo S, Pu WT. Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failure. Proc Natl Acad Sci USA 2006; 103: 14471-14476.
89. Heineke J, Auger-Messier M, Xu J, Oka T, Sargent MA, York A, Klevitsky R, Vaikunth S, Duncan SA, Aronow BJ, Robbins J, Crombleholme TM, Molkentin JD. Cardiomyocyte GATA4 functions as a stress-responsive regulator of angiogenesis in the murine heart. J Clin Invest 2007; 117: 3198-3210.
90. Uchida S, Fuke S, Tsukahara T. Upregulations of Gata4 and oxytocin receptor are important in cardiomyocyte differentiation processes of P19CL6 cells. J Cell Biochem 2007; 100: 629-641.
91. Abdelalim EM, Tooyama I. BNP signaling is crucial for embryonic stem cell proliferation. PLoS ONE 2009; 4: e5341.
92. Morris M, Castro M, Rose JC. Alterations in oxytocin prohormone processing during early development in the fetal sheep. Am J Physiol 1992; 263: R738-R740.
93. Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, Patano N, Strippoli M, Vergari R, Mancini L, Colucci S, Grano M, Faccio R, Liu X, Li J, Usmani S, Bachar M, Bab I, Nishimori K, Young LJ, Buettner C, Iqbal J, Sun L, Zaidi M, Zallone A. Oxytocin is an anabolic bone hormone. Proc Natl Acad Sci USA 2009; 106: 7149-7154.
94. Danalache BA, Gutkowska J, Slusarz MJ, Berezowska I, Jankowski M. Oxytocin-Gly-Lys-Arg: a novel cardiomyogenic peptide. PLoS ONE 2010; 5: e13643.
95. Lopaschuk GD, Spafford MA, Marsh DR. Glycolysis is predominant source of myocardial ATP production immediately after birth. Am J Physiol 1991; 261: H1698-H1705.
96. Hay WW Jr. Recent observations on the regulation of fetal metabolism by glucose. J Physiol 2006; 572: 17-24.
97. Sakuragawa N, Matsui A, Matsuzaka T, Kono Y, Ido T, Ishiwata K, Kawashima K. Enhanced glucose metabolism and impaired placental function in hypoxic pregnant rats. Int J Rad Appl Instrum B 1988; 15: 645-650.
98. Martin CM, Meeson AP, Robertson SM, Hawke TJ, Richardson JA, Bates S, Goetsch SC, Gallardo TD, Garry DJ. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004; 265: 262-275.
99. Scobioala S, Klocke R, Kuhlmann M, Tian W, Hasib L, Milting H, Koenig S, Stelljes M, El Banayosy A, Tenderich G, Michel G, Breithardt G, Nikol S. Up-regulation of nestin in the infarcted myocardium potentially indicates differentiation of resident cardiac stem cells into various lineages including cardiomyocytes. FASEB J 2008; 22: 1021-1031.
100. Laflamme MA, Myerson D, Saffitz JE, Murry CE. Evidence for cardiomyocyte repopulation by extracardiac progenitors in transplanted human hearts. Circ Res 2002; 90: 634-640.
101. Quaini F, Urbanek K, Beltrami AP, Finato N, Beltrami CA, Nadal-Ginard B, Kajstura J, Leri A, Anversa P. Chimerism of the transplanted heart. N Engl J Med 2002; 346: 5-15.